OKYO Pharma Ltd reports

Company location: London, United Kingdom

OKYO Pharma Ltd has filed 279 SEC EDGAR filings since 22 Mar 2021

Filter by type:
20-F
6-K

SEC filing history

Showing 1-6 of 6 matching filings.

Per page

25

Current page

1

20-F/A File 001-41386

20-F/A

Filing date: 12 Aug 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

20-F File 001-41386

20-F

Filing date: 18 Jul 2025
Reporting date: 31 Mar 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

20-F File 001-41386

20-F filing

Filing date: 13 Aug 2024
Reporting date: 31 Mar 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

20-F/A File 001-41386

20-F/A filing

Filing date: 25 Aug 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

20-F File 001-41386

20-F filing

Filing date: 15 Aug 2023
Reporting date: 31 Mar 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

20-F File 001-41386

20-F filing

Filing date: 15 Aug 2022
Reporting date: 31 Mar 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .